Vyne Therapeutics Inc (VYNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,646 | -14,366 | -8,611 | -39,834 | -27,812 |
| Depreciation Amortization | -670 | -526 | -318 | -2,439 | -1,899 |
| Accounts receivable | 1,939 | 306 | -768 | -899 | -1,587 |
| Other Working Capital | -8,823 | -8,664 | -3,295 | 4,999 | 2,134 |
| Other Operating Activity | -160 | 986 | 1,531 | 4,201 | 4,191 |
| Operating Cash Flow | $-29,360 | $-22,264 | $-11,461 | $-33,972 | $-24,973 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 28,908 | 24,506 | -13,769 | 23,482 | 10,627 |
| PPE Investments | N/A | N/A | N/A | -117 | N/A |
| Sale Of Investment | N/A | N/A | 33,600 | N/A | N/A |
| Investing Cash Flow | $28,908 | $24,506 | $19,831 | $23,365 | $10,627 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -128 | -121 | -87 | -141 | -9 |
| Financing Cash Flow | $-128 | $-121 | $-87 | $-141 | $-9 |
| Beginning Cash Position | 19,926 | 19,926 | 19,926 | 30,674 | 30,674 |
| End Cash Position | 19,346 | 22,047 | 28,209 | 19,926 | 16,319 |
| Net Cash Flow | $-580 | $2,121 | $8,283 | $-10,748 | $-14,355 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,360 | -22,264 | -11,461 | -33,972 | -24,973 |
| Capital Expenditure | N/A | N/A | N/A | -117 | N/A |
| Free Cash Flow | -29,360 | -22,264 | -11,461 | -34,089 | -24,973 |